AI Health Technology Revamps Share Option Scheme to Meet Updated HK Listing Rules

The latest update is out from Miji International Holdings Limited ( (HK:1715) ).

AI Health Technology Limited plans to terminate its existing share option scheme, adopted in 2018, and replace it with a new 2026 Share Option Scheme, subject to shareholder approval at the upcoming annual general meeting. The company currently has 6,000,000 outstanding options under the old scheme, which will remain valid and exercisable, but no new options will be granted under it once the new scheme is adopted.

The 2026 Share Option Scheme is designed to comply with the amended Chapter 17 of the Hong Kong listing rules that took effect in 2023, aligning the company’s equity incentive arrangements with updated regulatory requirements. Adoption of the new scheme is contingent on shareholder resolutions and Stock Exchange approval for listing shares issued upon option exercise, signalling a refresh of the company’s long-term incentive framework for employees and stakeholders.

More about Miji International Holdings Limited

AI Health Technology Limited is a Cayman-incorporated company listed on the Hong Kong Stock Exchange under stock code 1715. The group operates in the broader health technology sector, using share option schemes as part of its capital management and employee or stakeholder incentive structures within the Hong Kong market framework.

Average Trading Volume: 807,012

Technical Sentiment Signal: Buy

Current Market Cap: HK$187.6M

For an in-depth examination of 1715 stock, go to TipRanks’ Overview page.